Uygun, VedatÖzsan, NazanDaloğlu, HayriyeÖztürkmen, SedaYalçın, KorayKarasu, GülsünYeşilipek, Akif2021-11-302021-11-302021Uygun, V., Özsan, N., Daloğlu, H., Öztürkmen, S., Yalçın, K., Karasu, G., & Yeşilipek, A. (2021). Epstein-Barr virus-related lymphoproliferative disorders in T-cell repleted haploidentical transplantation with post-transplant cyclophosphamide. International journal of hematology, 10.1007/s12185-021-03267-8. Advance online publication.https://doi.org/10.1007/s12185-021-03267-8https://hdl.handle.net/20.500.12713/2288EBV-associated lymphoproliferative disorders (LPDs) are common in hematopoietic stem cell transplantation (HSCT) with T-cell-depleted grafts, but are extremely rare in HSCT patients with T-cell-replete grafts with post-transplant cyclophosphamide (PTCy). Here we present the cases of two pediatric patients who developed EBV-related LPD after T-cell-replete haplo-HSCT with PTCy. One of these is the first reported case of EBV-positive mucocutaneous ulcer (EBVMCU) developing after PTCy. EBV-related diseases are rare in T-cell-replete haplo-HSCT patients with PTCy. However, in patients with risk factors, it is reasonable to screen for EBV viremia for LPD.eninfo:eu-repo/semantics/closedAccessEBV-positive Mucocutaneous UlcerEpstein–Barr VirusLymphoproliferative DisorderPost-transplant CyclophosphamideArticle34826107WOS:0007228654000012-s2.0-85119955552Q310.1007/s12185-021-03267-8N/A